EAM Global Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-63,279
Closed -$1.71M 245
2022
Q3
$1.71M Buy
+63,279
New +$1.71M 0.45% 103
2020
Q3
Sell
-40,541
Closed -$990K 179
2020
Q2
$990K Sell
40,541
-69,398
-63% -$1.69M 0.45% 108
2020
Q1
$1.63M Sell
109,939
-26,504
-19% -$392K 0.95% 42
2019
Q4
$2.21M Buy
+136,443
New +$2.21M 0.89% 37
2018
Q2
Sell
-44,898
Closed -$1.38M 189
2018
Q1
$1.38M Hold
44,898
0.72% 36
2017
Q4
$1.61M Buy
+44,898
New +$1.61M 0.82% 10